24
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16130 | Mps1-IN-3 | Kinesin | |
Mps1-IN-3 is an effective and selective inhibitor of MPS1 kinase (IC50: 50 nM). | |||
T1839 | Mps1-IN-2 | Kinesin , PLK | |
Mps1-IN-2 is a potent, selective and ATP-competitive dual Mps1/Plk1 inhibitor. | |||
T12102 | Mps1-IN-1 | Others | |
Mps1-IN-1 is a potent, selective and ATP-competitive inhibitor of Mps1 kinase (IC50 : 367 nM ) | |||
T37050 | MPS1/TTK Inhibitor | MPS1/TTK Inhibitor | |
MPS1/TTK inhibitor is an inhibitor of monopolar spindle 1 (MPS1/TTK; IC50 = 5.8 nM), a kinase involved in mitotic spindle checkpoint signaling that is overexpressed in certain cancerous tumors. It inhibits MPS1 phosphory... | |||
T17007 | TC-Mps1-12 | Kinesin | |
TC-Mps1-12 is an effective and selective inhibitor of monopolar spindle 1 (IC50: 6.4 nM) . | |||
T70095 | Mps1-IN-1 dihydrochloride | ||
Mps1-IN-1 dihydrochloride, a potent ATP-competitive inhibitor of Mps1 kinase, exhibits an IC50 of 367 nM. It effectively inhibits the activity of Mps1 mitotic kinase and disrupts spindle assembly checkpoint (SAC) functio... | |||
T64061 | Mps1-IN-3 hydrochloride | ||
Mps1-IN-3 hydrochloride is a potent and selective inhibitor of Mps1 (IC50: 50 nM). mps1-IN-3 hydrochloride exhibits inhibitory effects on the proliferation of glioblastoma cells and effectively sensitizes glioblastomas t... | |||
T78965 | Mps1-IN-6 | ||
Mps1-IN-6 is a potent Mps1 inhibitor that demonstrates antiproliferative and antitumor activities, exhibiting an IC50 of 2.596 nM [1]. | |||
T73229 | Mps1-IN-4 | ||
Mps1-IN-4 is a compound that selectively inhibits Monopolar spindle 1 (Mps1), exhibiting antiproliferative properties useful in cancer research. | |||
T73308 | Mps1-IN-5 | ||
Mps1-IN-5 is a potent, orally active Mps1 inhibitor exhibiting an IC50 of 29 nM, known for triggering apoptosis and G2/M phase cell cycle arrest. This compound demonstrates antiproliferative and anti-tumor effects by inh... | |||
T23865 | CCT-271850 | MPS1-IN-77,MPS1IN77,CCT271850,CCT 271850,MPS1 IN 77 | |
CCT-271850 is an inhibitor of the spindle checkpoint function of Monospindle 1. | |||
T77779 | Mps1-IN-6 (Compound 9) | ||
Mps1-IN-6 (Compound 9) is a highly effective Mps1 inhibitor with an IC50 value of 6.4 nM and exhibits significant anti-proliferation and anti-tumor effects on breast cancer cells. | |||
T3434 | BAY1217389 | Kinesin | |
BAY 1217389 is an effective and selective inhibitor of the monopolar spindle 1 (MPS1) kinase (IC50<10 nM). | |||
T2689 | AZ3146 | AZ 3146 | Kinesin |
AZ3146 is a selective Mps1 inhibitor with IC50 of ~35 nM. | |||
T2313 | MPI-0479605 | Apoptosis , Kinesin | |
MPI-0479605 is an ATP competitive and selective inhibitor. | |||
T14765 | BOS-172722 | Kinesin | |
BOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint(IC50 of 2 nM). | |||
T8487 | Empesertib | BAY 1161909 | Kinesin |
Empesertib (BAY 1161909) is an orally bioavailable and selective inhibitor Mps1(IC50 < 1 nM), with potential antineoplastic activity. | |||
T12237 | NMS-P715 | Casein Kinase , Kinesin , MELK , MAPK | |
NMS-P715 is a selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM). | |||
T22289 | CFI-402257 | Kinesin | |
CFI-402257 is a selective inhibitor of Mps1/TTK kinase (Mps1 Ki = 0.09 nM; EC50 = 6.5 nM)and can be used in studies about hepatocellular carcinoma diseases. | |||
T14906 | CCT251455 | Kinesin | |
CCT251455 is an inhibitor of mitotic kinase monopolar spindle 1 (MPS1; IC50: 3 nM). | |||
T28091 | Mps-BAY2b | ||
Mps-BAY2b is a novel MPS1 inhibitor. | |||
T73483 | RMS-07 | ||
RMS-07, a covalent inhibitor of Monopolar Spindle Kinase 1 (MPS1/TTK), exhibits a potent inhibitory concentration (IC50) of 13.1 nM. Specifically, it targets a poorly conserved cysteine located in the hinge region of the... | |||
T28498 | Rac-CCT-250863 | ||
Rac-CCT-250863, a potent Nek2 inhibitor, exhibits selectivity for Nek2 over PLK1, MPS1, Cdk2 and Aurora A. | |||
T71082 | DW532 | ||
DW532 is one of simplified analogues of hematoxylin that has shown broad-spectrum inhibition on tyrosine kinases and in vitro anti-cancer activities. DW532 inhibited EGFR and VEGFR2 in vitro kinase activity (the IC50 val... |